-
Innovation Ranking
NewInnovation Ranking – TPI Composites Inc
TPI Composites Inc (TPI) is a provider of wind energy products and composite materials. The company designs and manufactures composite wind blades and provides single source solutions to the global wind turbine manufacturers. It provides precision molding and assembly systems used for wind blades to original equipment manufacturers. TPI also designs and manufactures composite solutions for the transportation industry and inspection and repair services. The company has its operations and manufacturing facilities across the US, China, Mexico, India, Germany, Denmark,...
-
Sector Analysis
NewUnited Kingdom (UK) Financial Advisors Market Overview by Financial Advice Firms, Opportunities and Threats, 2023 Update
United Kingdom (UK) Financial Advisors Market Report Overview The UK financial advisors market is undergoing a period of consolidation, as a result, the composition of the market is changing slowly but surely owing to ready sellers and willing buyers. Single advisor firms still dominate the market. However, the average number of advisors per firm is rising, indicating a shift towards medium-sized and large outfits. Financial advisors play an important role in serving retired individuals and those approaching retirement. However, the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TBI-304H in Chemotherapy Induced Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TBI-304H in Chemotherapy Induced Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TBI-304H in Chemotherapy Induced Anemia Drug Details: TBI-304H is under development...
-
Sector Analysis
NewNew Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called "CMO Scorecard") is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ANX-005 in Guillain-Barre Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ANX-005 in Guillain-Barre Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ANX-005 in Guillain-Barre Syndrome Drug Details: ANX-005 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CM-101 in Liver Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CM-101 in Liver Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CM-101 in Liver Fibrosis Drug Details: CM-101 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ANX-005 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ANX-005 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ANX-005 in Amyotrophic Lateral Sclerosis Drug Details: ANX-005 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CM-101 in Primary Sclerosing Cholangitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CM-101 in Primary Sclerosing Cholangitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CM-101 in Primary Sclerosing Cholangitis Drug Details: CM-101 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RNS-60 in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RNS-60 in Acute Ischemic Stroke report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RNS-60 in Acute Ischemic Stroke Drug Details: RNS-60 is under development...